Navigation Links
Proove Biosciences Announces Sponsorship of National Drug Take Back Day and HC DrugFree

IRVINE, CA (PRWEB) October 24, 2013

Proove Biosciences, the leader in personalized pain medication innovation, is proud to be a Silver Sponsor partner of HC DrugFree and participant in National Drug Take Back Day this Saturday, October 26, 2013. HC DrugFree will be hosting the event at multiple locations throughout Howard County, Maryland in order to make it more convenient for all residents to participate.

This week’s National Drug Take Back Day coincides with the Medicine Abuse Project’s Mind Your Meds week - a week-long effort asking the public to show support for ending teen medicine abuse by safeguarding and disposing of prescription medicines at home. These events play a small role in the larger initiative of Medicine Abuse Awareness month, which takes place during the entire month of October.

Proove Biosciences will be providing “Mind Your Meds” T-shirts to the HC DrugFree’s Teen Advisory Council, which provides the youth perspective to staff and Board members of HC DrugFree. The Teen Advisory Council is composed of Howard County high school students who meet monthly to discuss teen drug and alcohol use, and develop educational messages that promote HC DrugFree’s vision.

HC DrugFree is a non-profit based out of Howard County, Maryland established to respond to the alarming number of teens using illegal substances in the community. Over the years, HC DrugFree has expanded as more high schools around the county became involved in providing substance abuse education. Joan Webb Scornaienchi serves as HC DrugFree’s executive director, and has over 20 years of experience in higher education.

“As a business, Proove Biosciences is active member of the Howard County Community and a socially-responsible enterprise. We are proud to sponsor and support Joan and the entire HC DrugFree team,” states Brian Meshkin, President and Founder of Proove Biosciences. “We sponsored last year’s record-collecting events in Howard County through HC DrugFree. Proove is happy to support and help strengthen this initiative. Ensuring prescription medications are responsibly disposed of is key to reducing the risk of teen abuse. Spreading the awareness of this issue and protecting children is foundational to Proove’s mission of reducing narcotic dependence risk and increasing safety through genetic testing and risk assessment.” Brian Meshkin also serves as the Vice-Chairman of the Board of Education in Howard County, Maryland.

About Proove Biosciences
Proove Biosciences is the leading Personalized Pain Medicine laboratory that provides proprietary genetic testing services to help physicians improve outcomes for patients and contain costs for insurers. With offices in Southern California and the Baltimore-Washington metropolitan area, the Company is the research leader investigating and publishing data on the genetics of pain medicine with clinical research sites across the United States. Physicians use Proove Biosciences testing to improve pain medicine selection, dosing, and evaluation of medications they prescribe. From a simple cheek swab collected in the office, Proove performs proprietary genetic tests in its CLIA-certified laboratory to identify patients at risk for misuse of prescription pain medications and evaluate their metabolism of medications. For more information, please visit or call toll free 855-PROOVE-BIO (855-776-6832).

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Proove Biosciences Will Participate at the California Society of Interventional Pain Physician’s 4th Annual Meeting This Weekend
2. Proove CEO and Vice Chairman of the Howard County Board of Education, Brian Meshkin, Selected as one of Howard County's Finest Under 39 by the Cystic Fibrosis Foundation
3. Proove Biosciences Continues Its Research Leadership in the Genetics of Pain Medicine at The American Academy of Pain Management’s 24th Annual Meeting
4. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
5. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
6. Coronado Biosciences to Present at the Oppenheimer 22nd Annual Healthcare Conference
7. Coronado Biosciences Announces Phase 1 Results of CNDO-109 in AML to be Presented at the American Society of Hematology
8. Sangamo BioSciences Announces Presentation of New Data from ZFP Therapeutic® Program in Hemophilia B at American Society for Hematology Meeting
9. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
10. Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology
11. Sangamo BioSciences Announces Fourth Quarter and Full Year 2011 Conference Call and Webcast
Post Your Comments:
(Date:11/25/2015)... BRUSSELS , November 25, 2015 ... la première fois les différences entre les souches ... de celles des êtres humains . Ces ... comprendre et envisager la prise en charge efficace de ... ent diagnostiqués chez les chats .    --> ...
(Date:11/25/2015)... and HOLLISTON, Mass. , ... Inc. (Nasdaq: HART ), a biotechnology company developing ... CEO Jim McGorry will present at the ... 1, 2015 at 2:30 p.m. PT. The presentation will ... for 30 days. Management will also be available at ...
(Date:11/25/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: ... prospects remain fundamentally strong and highlights the following ... received DSMB recommendation to continue the ZoptEC Phase ... the final interim efficacy and safety data ... men with heavily pretreated castration- and Taxane-resistant prostate ...
(Date:11/25/2015)... SAN DIEGO , Nov. 25, 2015 ... that management will participate in a fireside chat discussion ... New York . The discussion is ... Time. .  A replay will ... Contact:  Media Contact:McDavid Stilwell  , Julie NormartVP, Corporate ...
Breaking Biology Technology:
(Date:11/10/2015)... YORK , Nov. 10, 2015 ... to behavioral biometrics that helps to identify and ... fraud. Signature is considered as the secure and ... the identification of a particular individual because each ... more accurate results especially when dynamic signature of ...
(Date:11/2/2015)... 2, 2015  SRI International has been awarded a ... development services to the National Cancer Institute (NCI) PREVENT ... scientific expertise, modern testing and support facilities, and analytical ... and toxicology studies to evaluate potential cancer prevention drugs. ... PREVENT Cancer Drug Development Program is an NCI-supported pipeline ...
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
Breaking Biology News(10 mins):